Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical ...

The Melville, New York-based company’s soon-to-be new CEO succeeds Stanley M. Bergman, who stepped down from the post.

The new CEO will succeed Stanley Bergman, who has led the pharmaceuticals and healthcare products distributor for the past 35 ...

Henry Schein has named Federick M. Lowery as its new CEO effective March 2, 2026. He will also join the company’s board of ...

Stanley Bergman has worked at Henry Schein for 45 years, more than 35 of which he spent as CEO, and was due to retire at the ...

Facility Designed To Improve Efficiency, Enable Innovation, and Better Serve Customers; Modernized, 811K Square Foot Facility in Fort Worth Largest in the Company’s Network MELVILLE, N.Y.--(BUSINESS ...

Shares of dental and medical products company Henry Schein (NASDAQ:HSIC) fell 2.7% in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical ...

Henry Schein HSIC is well positioned to gain from its extensive global foothold and diverse channel mix. Yet, global economic uncertainties are concerns for Henry Schein. The stock carries a Zacks ...

Forbes contributors publish independent expert analyses and insights. #1 stock picker for 51 straight months on SumZero. AI is my edge. This firm overcame a decline in dental services and supply chain ...

Mr. Lowery brings more than two decades of healthcare expertise to Henry Schein, with a strong track record of scaling complex businesses to drive significant growth and sustained value creation. Most ...

Henry Schein appoints Frederick Lowery as CEO, succeeding Stanley Bergman to lead growth and strategic initiatives in dental ...